Filing Details
- Accession Number:
- 0001209191-15-022576
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-04 19:20:13
- Reporting Period:
- 2015-03-03
- Filing Date:
- 2015-03-04
- Accepted Time:
- 2015-03-04 19:20:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1430426 | P Vincent Ippolito | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-03-03 | 7,846 | $43.81 | 71,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-03 | 1,154 | $44.34 | 70,603 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.24 to $44.16, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.30 to $44.42, inclusive.
Billionaire Hedge Funds
